Literature DB >> 12427706

The 2002 Canadian bone densitometry recommendations: take-home messages.

Aliya A Khan1, Jacques P Brown, David L Kendler, William D Leslie, Brian C Lentle, E Michael Lewiecki, Paul D Miller, R Lawrence Nicholson, Wojciech P Olszynski, Nelson B Watts.   

Abstract

Mesh：

Year:  2002        PMID： 12427706      PMCID： PMC134295     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  29 in total

1.  Assessing bone density in men.

Authors:  E Orwoll
Journal:  J Bone Miner Res       Date:  2000-10       Impact factor: 6.741

2.  An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation.

Authors:  J A Kanis; C C Glüer
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

3.  A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

Authors:  C H Chesnut; S Silverman; K Andriano; H Genant; A Gimona; S Harris; D Kiel; M LeBoff; M Maricic; P Miller; C Moniz; M Peacock; P Richardson; N Watts; D Baylink
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

4.  Reproducibility of DXA: potential impact on serial measurements and misclassification of osteoporosis.

Authors:  G Phillipov; C J Seaborn; P J Phillips
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

5.  An assessment tool for predicting fracture risk in postmenopausal women.

Authors:  D M Black; M Steinbuch; L Palermo; P Dargent-Molina; R Lindsay; M S Hoseyni; O Johnell
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

Review 6.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Authors:  Jacques P Brown; Robert G Josse
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

7.  Pre-existing fractures and bone mass predict vertebral fracture incidence in women.

Authors:  P D Ross; J W Davis; R S Epstein; R D Wasnich
Journal:  Ann Intern Med       Date:  1991-06-01       Impact factor: 25.391

8.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

9.  Appendicular bone mineral and a woman's lifetime risk of hip fracture.

Authors:  D M Black; S R Cummings; L J Melton
Journal:  J Bone Miner Res       Date:  1992-06       Impact factor: 6.741

10.  Standards and guidelines for performing central dual X-ray densitometry from the Canadian panel of International Society for Clinical Densitometry.

Authors:  A A Khan; J Brown; K Faulkner; D Kendler; B Lentle; W Leslie; P D Miller; L Nicholson; W P Olszynski; N B Watts; D Hanley; A Hodsman; R Josse; T M Murray; K Yuen
Journal:  J Clin Densitom       Date:  2002       Impact factor: 2.963
View more
  12 in total

1.  CANM endorsement of densitometry guidelines.

Authors:  Christopher J M O'Brien
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

2.  Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care.

Authors:  Angela M Cheung; Denice S Feig; Moira Kapral; Natalia Diaz-Granados; Sylvie Dodin
Journal:  CMAJ       Date:  2004-05-25       Impact factor: 8.262

3.  Low bone mineral density is two to three times more prevalent in non-athletic premenopausal women than in elite athletes: a comprehensive controlled study.

Authors:  M K Torstveit; J Sundgot-Borgen
Journal:  Br J Sports Med       Date:  2005-05       Impact factor: 13.800

4.  Canadian Consensus Conference on osteoporosis, 2006 update.

Authors:  Jacques P Brown; Michel Fortier; Heather Frame; André Lalonde; Alexandra Papaioannou; Vyta Senikas; Chui Kin Yuen
Journal:  J Obstet Gynaecol Can       Date:  2006-02

5.  Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus.

Authors:  S Gul Oz; Gulay Sain Guven; Alpaslan Kilicarslan; Nursel Calik; Yavuz Beyazit; Tumay Sozen
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

6.  Risk of fractures and bone abnormalities in postmenopausal women with type 2 diabetes mellitus.

Authors:  Maria Giovanna Filippella; Antongiulio Faggiano; Alberto Falchetti; Annamaria Colao; Carlo Rosa; Carlo Poti; Corrado Musso; Giulio Doveri; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2010-05

Review 7.  Osteoporosis in children and adolescents: etiology and management.

Authors:  Giampiero Igli Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

8.  Effect of Medicare reimbursement reduction for imaging services on osteoporosis screening rates.

Authors:  Carrie McAdam-Marx; Sudhir Unni; Xiangyang Ye; Scott Nelson; Nancy A Nickman
Journal:  J Am Geriatr Soc       Date:  2012-02-13       Impact factor: 5.562

Review 9.  Advances in osteoporosis therapy. 2003 update of practical guidelines.

Authors:  Aliya Khan
Journal:  Can Fam Physician       Date:  2003-04       Impact factor: 3.275

Review 10.  Adverse effects of antiretroviral therapy for HIV infection.

Authors:  Valentina Montessori; Natasha Press; Marianne Harris; Linda Akagi; Julio S G Montaner
Journal:  CMAJ       Date:  2004-01-20       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.